Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐1
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
The mechanisms underlying the development of glomerular lesions during aging are largely unknown. It has been suggested that senescence might play a role, but the pathophysiological link between senescence and lesion development remains unexplained. Here, we uncovered an unexpected role for glomerular endothelial cells during aging. In fact, we discovered a detrimental cross‐talk between senescent endothelial cells and podocytes, through PAI‐1. In vivo , selective inactivation of PAI‐1 in endothelial cells protected glomeruli from lesion development and podocyte loss in aged mice. In vitro , blocking PAI‐1 in supernatants from senescent endothelial cells prevented podocyte apoptosis. Consistently, depletion of senescent cells prevented podocyte loss in old p16 INK‐ATTAC transgenic mice. Importantly, these experimental findings are relevant to humans. We showed that glomerular PAI‐1 expression was predictive of poor outcomes in transplanted kidneys from elderly donors. In addition, we observed that in elderly patients, urinary PAI‐1 was associated with age‐related chronic kidney disease. Altogether, these results uncover a novel mechanism of kidney disease and identify PAI‐1 as a promising biomarker of kidney dysfunction in allografts from elderly donors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Senescent podocytes in old mouse kidneys overexpress senescence markers and SASP factors, including Irf5, Cebpb, Jdp2, Ccl2, Ccl3, Ccl5, Ccl8, Mmp12, Mmp13 and Gsk3b.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [140]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescent cells are also observed in kidneys of mouse models of acute kidney injury, diabetic nephropathy, glomerulonephropathy, chronic kidney disease and chronic ischaemic renal injury140,144–150.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serpine1 overexpression causes podocyte detachment and apoptosis, resulting in glomerulosclerosis140.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SERPINE1 drives glomerulosclerosis in early kidney injury in diabetes140,148.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [140]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · cited 1×
“The estimated glomerular filtration rate was calculated using the CKD-EPI equation (Levey et al, 2009).”
MethodDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · cited 1×
“Recent studies report that CKD affects 15–38% of people older than 65 years, and rises up to 50% in people older than 85 years (Coresh et al, 2007; Hill et al, 2016).”
BackgroundGlobal Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030 · cited 1×
“Recent studies report that CKD affects 15–38% of people older than 65 years, and rises up to 50% in people older than 85 years (Coresh et al, 2007; Hill et al, 2016).”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“When they reach a critical size, the DNA damage response (DDR) is activated leading to senescence (d’Adda di Fagagna et al, 2003; Kuilman et al, 2010).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 12×
“This transgenic model is characterized by the clearance of p16-positive cells in the presence of AP20187 (Baker et al, 2016).”
BackgroundMethodInfluentialSelf-citationCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“These molecules play a critical role during development and wound healing, but they are also detrimental in pathological processes by favoring a local pro-fibrotic and proinflammatory environment (Kuilman et al, 2008; Childs et al, 2015; Watanabe et al, 2017).”
BackgroundSelf-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 2×
“SASP includes pro-inflammatory cytokines, growth factors, proteases, and extracellular matrix components (Kuilman et al, 2008; Salama et al, 2014; Watanabe et al, 2017).”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 3×
“Senescence can be triggered by different stimuli (Kuilman et al, 2010).”
Background
Cited by
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“Senescent cells are also observed in kidneys of mouse models of acute kidney injury, diabetic nephropathy, glomerulonephropathy, chronic kidney disease and chronic ischaemic renal injury 140,144–150 .”
InfluentialSelf-citationA systems view of the vascular endothelium in health and disease
Augustin, H. G., & Koh, G. Y. (2024) · Cell · doi:10.1016/j.cell.2024.07.012 · Cited by 343
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Metadata
- Authors
- Cohen, C., Le Goff, O., Soysouvanh, F., Vasseur, F., Tanou, M., Nguyen, C., Amrouche, L., Le Guen, J., Saltel‐Fulero, O., Meunier, T., Nguyen‐Khoa, T., Rabant, M., Nochy, D., Legendre, C., Friedlander, G., Childs, B. G., Baker, D. J., Knebelmann, B., Anglicheau, D., Milliat, F., & Terzi, F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Institut de Radioprotection et de Sûreté Nucléaire (FR)
- Hôpital Necker-Enfants Malades (FR)
- Université Paris Cité (FR)
- Mayo Clinic (US)
- Corresponding author
- Terzi, Fabiola
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2021-11-02
- Volume
- 13
- Issue
- 11
- Pages
- e14146-e14146
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC8573606
- OpenAlex
- W3209587033
- Cited by
- 79
- References
- 61
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 15 · 2023: 19 · 2022: 8 · 2021: 1
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Universite de Paris
- Assistance Publique ‐ Hôpitaux de Paris
- Agence Nationale Recherche
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- age-related kidney disease, plasminogen activator inhibitor-1, podocyte loss, podocyte apoptosis, p16INK4a, chronic kidney disease, biomarkers, glomerular lesions
- MeSH terms
- Aged, Animals, Humans, Kidney Diseases, Kidney Glomerulus, Cellular Senescence, Plasminogen Activator Inhibitor 1, Endothelial Cells, Podocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐1. https://app.cochat.ai/papers/10.15252/emmm.202114146
- The paper
- Cohen, C., Le Goff, O., Soysouvanh, F., Vasseur, F., Tanou, M., Nguyen, C., Amrouche, L., Le Guen, J., Saltel‐Fulero, O., Meunier, T., Nguyen‐Khoa, T., Rabant, M., Nochy, D., Legendre, C., Friedlander, G., Childs, B. G., Baker, D. J., Knebelmann, B., Anglicheau, D., . . . Terzi, F. (2021). Glomerular endothelial cell senescence drives age‐related kidney disease through PAI‐1. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202114146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.